The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications
The insulin receptor (IR) presents by alternative splicing two isoforms: IRA and IRB. The differential physiological and pathological role of both isoforms is not completely known, and it is determinant the different binding affinity for insulin-like growth factor. IRB is more abundant in adult tiss...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2017/1403206 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561971398967296 |
|---|---|
| author | O. Escribano N. Beneit C. Rubio-Longás A. R. López-Pastor A. Gómez-Hernández |
| author_facet | O. Escribano N. Beneit C. Rubio-Longás A. R. López-Pastor A. Gómez-Hernández |
| author_sort | O. Escribano |
| collection | DOAJ |
| description | The insulin receptor (IR) presents by alternative splicing two isoforms: IRA and IRB. The differential physiological and pathological role of both isoforms is not completely known, and it is determinant the different binding affinity for insulin-like growth factor. IRB is more abundant in adult tissues and it exerts mainly the metabolic actions of insulin, whereas IRA is mainly expressed in fetal and prenatal period and exerts mitogenic actions. However, the change in the expression profile of both IR isoforms and its dysregulation are associated with the development of different pathologies, such as cancer, insulin resistance, diabetes, obesity, and atherosclerosis. In some of them, there is a significant increase of IRA/IRB ratio conferring a proliferative and migratory advantage to different cell types and favouring IGF-II actions with a sustained detriment in the metabolic effects of insulin. This review discussed specifically the role of IR isoforms as well as IGF-IR in diabetes and its associated complications as obesity and atherosclerosis. Future research with new IR modulators might be considered as possible targets to improve the treatment of diabetes and its associated complications. |
| format | Article |
| id | doaj-art-4ef7325169084adaaf3085b9d568b14b |
| institution | Kabale University |
| issn | 2314-6745 2314-6753 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Research |
| spelling | doaj-art-4ef7325169084adaaf3085b9d568b14b2025-02-03T01:23:43ZengWileyJournal of Diabetes Research2314-67452314-67532017-01-01201710.1155/2017/14032061403206The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular ComplicationsO. Escribano0N. Beneit1C. Rubio-Longás2A. R. López-Pastor3A. Gómez-Hernández4Biochemistry and Molecular Biology II Department, School of Pharmacy, Complutense University of Madrid, Madrid, SpainBiochemistry and Molecular Biology II Department, School of Pharmacy, Complutense University of Madrid, Madrid, SpainBiochemistry and Molecular Biology II Department, School of Pharmacy, Complutense University of Madrid, Madrid, SpainBiochemistry and Molecular Biology II Department, School of Pharmacy, Complutense University of Madrid, Madrid, SpainBiochemistry and Molecular Biology II Department, School of Pharmacy, Complutense University of Madrid, Madrid, SpainThe insulin receptor (IR) presents by alternative splicing two isoforms: IRA and IRB. The differential physiological and pathological role of both isoforms is not completely known, and it is determinant the different binding affinity for insulin-like growth factor. IRB is more abundant in adult tissues and it exerts mainly the metabolic actions of insulin, whereas IRA is mainly expressed in fetal and prenatal period and exerts mitogenic actions. However, the change in the expression profile of both IR isoforms and its dysregulation are associated with the development of different pathologies, such as cancer, insulin resistance, diabetes, obesity, and atherosclerosis. In some of them, there is a significant increase of IRA/IRB ratio conferring a proliferative and migratory advantage to different cell types and favouring IGF-II actions with a sustained detriment in the metabolic effects of insulin. This review discussed specifically the role of IR isoforms as well as IGF-IR in diabetes and its associated complications as obesity and atherosclerosis. Future research with new IR modulators might be considered as possible targets to improve the treatment of diabetes and its associated complications.http://dx.doi.org/10.1155/2017/1403206 |
| spellingShingle | O. Escribano N. Beneit C. Rubio-Longás A. R. López-Pastor A. Gómez-Hernández The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications Journal of Diabetes Research |
| title | The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications |
| title_full | The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications |
| title_fullStr | The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications |
| title_full_unstemmed | The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications |
| title_short | The Role of Insulin Receptor Isoforms in Diabetes and Its Metabolic and Vascular Complications |
| title_sort | role of insulin receptor isoforms in diabetes and its metabolic and vascular complications |
| url | http://dx.doi.org/10.1155/2017/1403206 |
| work_keys_str_mv | AT oescribano theroleofinsulinreceptorisoformsindiabetesanditsmetabolicandvascularcomplications AT nbeneit theroleofinsulinreceptorisoformsindiabetesanditsmetabolicandvascularcomplications AT crubiolongas theroleofinsulinreceptorisoformsindiabetesanditsmetabolicandvascularcomplications AT arlopezpastor theroleofinsulinreceptorisoformsindiabetesanditsmetabolicandvascularcomplications AT agomezhernandez theroleofinsulinreceptorisoformsindiabetesanditsmetabolicandvascularcomplications AT oescribano roleofinsulinreceptorisoformsindiabetesanditsmetabolicandvascularcomplications AT nbeneit roleofinsulinreceptorisoformsindiabetesanditsmetabolicandvascularcomplications AT crubiolongas roleofinsulinreceptorisoformsindiabetesanditsmetabolicandvascularcomplications AT arlopezpastor roleofinsulinreceptorisoformsindiabetesanditsmetabolicandvascularcomplications AT agomezhernandez roleofinsulinreceptorisoformsindiabetesanditsmetabolicandvascularcomplications |